The Department of Health through the Health Facilities and Services Regulatory Bureau (HFSRB), the Bioethics Advisory Board (BAB), and the Food and Drug Administration (FDA) has drafted policy guidelines in the regulation of Stem Cell products and facilities repealing DOH AO No. 2013-0012 or the “Rules and Regulations Governing the Accreditation of Health Facilities Engaging in Human Stem Cell and Stem-Cell Based or Cellular Therapies in the Philippines” dated 18 March 2013.
In the interest of service and to seek the inputs of stakeholders, the DOH is respectfully you to participate in this advisory.
Further, provided herewith is the link for your reference https://bit.ly/3P9JHAU
Thank you very much.
